 ENGLEWOOD, CO ACCESSWIRE August 24, 2022 Aytu BioPharma, Inc. NASDAQ:AYTU, a pharmaceutical company focused on commercializing novel therapeutics, with a development pipeline addressing rare, pediatric-onset disorders, today announced that Aytus management team will virtually present at, and participate in, the upcoming H.C. Wainwright 24th Annual Global Investment Conference and Lytham Partners Fall 2022 Investor Conference. 